According to FutureWise analysis, the market for CD68 is expected to register a CAGR of 13.10% from 2025 to 2033. CD68 (Cluster of Differentiation 68) is a protein that is expressed by monocytes, tissue macrophages, and circulating macrophages. It is widely used as a diagnostic and prognostic marker in cancer, helping to identify neoplasms associated with macrophage lineages as well as tumor...